Creative Medical Technology Holdings, Inc. (CELZ)
1.04
-0.04
(-3.70%)
USD |
NASDAQ |
Sep 09, 16:00
1.04
0.00 (0.00%)
After-Hours: 16:50
Creative Medical Technology Holdings Price to Book Value : 0.7801 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.8101 |
| September 04, 2026 | 0.8326 |
| September 03, 2026 | 0.7951 |
| September 02, 2026 | 0.8476 |
| September 01, 2026 | 0.8251 |
| August 31, 2026 | 0.8476 |
| August 28, 2026 | 0.8551 |
| August 27, 2026 | 0.8551 |
| August 26, 2026 | 0.8926 |
| August 25, 2026 | 0.9301 |
| August 24, 2026 | 0.9076 |
| August 21, 2026 | 0.9826 |
| August 20, 2026 | 0.9601 |
| August 19, 2026 | 0.8401 |
| August 18, 2026 | 0.8101 |
| August 17, 2026 | 0.8251 |
| August 14, 2026 | 0.9151 |
| August 13, 2026 | 0.9301 |
| August 12, 2026 | 0.9001 |
| August 11, 2026 | 0.9301 |
| August 10, 2026 | 0.9001 |
| August 07, 2026 | 1.065 |
| August 06, 2026 | 0.8626 |
| August 05, 2026 | 0.5017 |
| August 04, 2026 | 0.4924 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.4907 |
| July 31, 2026 | 0.4981 |
| July 30, 2026 | 0.5733 |
| July 29, 2026 | 0.5191 |
| July 28, 2026 | 0.5524 |
| July 27, 2026 | 0.595 |
| July 24, 2026 | 0.6077 |
| July 23, 2026 | 0.6079 |
| July 22, 2026 | 0.631 |
| July 21, 2026 | 0.6232 |
| July 20, 2026 | 0.6473 |
| July 17, 2026 | 0.6593 |
| July 16, 2026 | 0.6451 |
| July 15, 2026 | 0.6166 |
| July 14, 2026 | 0.6317 |
| July 13, 2026 | 0.6408 |
| July 10, 2026 | 0.6842 |
| July 09, 2026 | 0.7061 |
| July 08, 2026 | 0.7501 |
| July 07, 2026 | 0.8176 |
| July 06, 2026 | 0.8626 |
| July 02, 2026 | 0.9076 |
| July 01, 2026 | 0.9526 |
| June 30, 2026 | 1.088 |
| June 29, 2026 | 0.4902 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.646 |
| Alnylam Pharmaceuticals, Inc. | 25.48 |
| Anika Therapeutics, Inc. | 2.036 |
| Savara, Inc. | 7.742 |
| Vericel Corp. | 5.395 |
Price to Book Value Related Metrics
| PS Ratio | 1185.65 |
| Price | 1.04 |
| Earnings Yield | -170.9% |
| Market Cap | 6.752M |